| 產(chǎn)品詳情 |
| Edit |   |
|---|
| Product Name | CY 09 |
|---|
| Description | NLRP3 inhibitor (Kd = 500 nM); directly binds to ATP-binding motif of NLRP3 NACHT domain. Blocks NLRP3 inflammasome assembly and activation. Displays therapeutic effects on mouse models of cryopyrin-associated autoinflammatory syndrome (CAPS) and type 2 diabetes. Exhibits no activity for hERG (10 μM). Purity 98%. MW (observed): 423.43 |
|---|
| Size | 50 mg |
|---|
| Concentration | n/a |
|---|
| Applications | n/a |
|---|
| Other Names | 4-[[4-Oxo-2-thioxo-3-[[3-(trifluoromethyl)phenyl]methyl]-5-thiazolidinylidene]methyl]benzoic acid |
|---|
| Gene, Accession, CAS # | CAS: 1073612-91-5 |
|---|
| Catalog # | 6436/50 |
|---|
| Price | |
|---|
| Order / More Info | CY 09 from TOCRIS BIOSCIENCE
|
|---|
| Product Specific References | n/a |
|---|
| 產(chǎn)品資料 |
|
|